US judge paves way for branded and generic opioid makers to face landmark October trial
A US judge has thwarted efforts by major drug manufacturers, distributors and pharmacies to reject claims that they played a pivotal role behind the opioid crisis that has ravaged the United States.
In doing so, district judge Dan Polster has cleared the path for a scheduled landmark trial, even as he pushes for a nationwide settlement, noted a Reuters report on Tuesday. Polster is presiding over more than 2,000 opioid lawsuits filed by states, counties and cities. Opioid-related overdoses have claimed almost 400,000 lives from 1999 to 2017, the CDC estimates.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
